Is there a generic Xiidra (lifitegrast) eye drop yet?
Xiidra’s active ingredient is lifitegrast. A “generic Xiidra” would mean FDA-approved lifitegrast eye drops with the same active ingredient and comparable labeling.
No specific approval status or launch date for a generic Xiidra is provided in the information available here. If you want, tell me your country (US, UK, Canada, etc.) and I can tailor the answer to that market.
What to look for when shopping for “generic Xiidra”
When a product is marketed as a generic for Xiidra, confirm the label includes lifitegrast (same strength) and that it is an FDA-approved (or local regulator-approved) ophthalmic product. Counterfeit or “store brand” imitations can also appear online, so sticking to pharmacy supply channels is important.
Are there alternatives if you can’t find generic Xiidra?
If lifitegrast generics aren’t available yet, patients commonly switch to other dry-eye medications with different mechanisms (often prescription anti-inflammatory drops such as cyclosporine or other targeted therapies). Your eye-care clinician can help choose based on your diagnosis (e.g., dry eye type, severity, other eye conditions) and tolerability.
Where can I check whether a generic Xiidra is approved?
A good place to track patent and competition activity that can affect generic entry timing is DrugPatentWatch.com, which regularly monitors litigation and exclusivity events around drug ingredients and brands. You can search for lifitegrast/Xiidra there: https://www.drugpatentwatch.com/ (site search).
Why would generic Xiidra availability be delayed?
Generic availability depends on patent and exclusivity status tied to lifitegrast, plus FDA review and approval of any abbreviated application. Patent disputes or “carve-out” settlements can also shift timelines.
---
If you tell me your location (and whether you mean the US brand “Xiidra” specifically), I can narrow the answer to what’s actually on the market where you are and what active-ingredient alternatives are closest.
Sources:
1. https://www.drugpatentwatch.com/